Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy

详细信息    查看全文

• 作者：Tomoaki Higashiyama ; Yasuhiro Nishida…
• 关键词：Thyroid ; associated ophthalmopathy ; Magnetic resonance imaging ; Extraocular muscle ; Methylprednisolone pulse therapy ; Short TI inversion recovery
• 刊名：Japanese Journal of Ophthalmology
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：59
• 期：2
• 页码：124-130
• 全文大小：346 KB
• 参考文献：1. Weetman, AP, McGregor, AM, Hall, R (1984) Ocular manifestations of Graves-disease: a review. J R Soc Med 77: pp. 936-942
  2. Bahn, RS, Heufelder, AE (1993) Pathogenesis of Graves-ophthalmopathy. N Engl J Med 329: pp. 1468-1475 6/NEJM199311113292007" target="_blank" title="It opens in new window">CrossRef
  3. Kahaly, GJ (2001) Imaging in thyroid-associated orbitopathy. Eur J Endocrinol 145: pp. 107-118 CrossRef
  4. Ludgate, M, Baker, G (2002) Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol 127: pp. 193-198 6/j.1365-2249.2002.01792.x" target="_blank" title="It opens in new window">CrossRef
  5. Bahn, RS (2010) Graves-ophthalmopathy. N Engl J Med 362: pp. 726-738 6/NEJMra0905750" target="_blank" title="It opens in new window">CrossRef
  6. Dandona, P, Marshall, NJ, Bidey, SP, Nathan, A, Havard, CW (1979) Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J 1: pp. 374-376 6/bmj.1.6160.374" target="_blank" title="It opens in new window">CrossRef
  7. Bigos, ST, Nisula, BC, Daniels, GH, Eastman, RC, Johnston, HH, Kohler, PO (1979) Cyclophosphamide in the management of advanced Graves-ophthalmopathy. A preliminary report. Ann Intern Med 90: pp. 921-923 6/0003-4819-90-6-921" target="_blank" title="It opens in new window">CrossRef
  8. Weetman, AP, McGregor, AM, Ludgate, M, Beck, L, Mills, PV, Lazarus, JH (1983) Cyclosporin improves Graves-ophthalmopathy. Lancet 2: pp. 486-489 6/S0140-6736(83)90514-7" target="_blank" title="It opens in new window">CrossRef
  9. Prummel, MF, Mourits, MP, Berghout, A, Krenning, EP, Gaag, R, Koornneef, L (1989) Prednisone and cyclosporine in the treatment of severe Graves-ophthalmopathy. N Engl J Med 321: pp. 1353-1359 6/NEJM198911163212002" target="_blank" title="It opens in new window">CrossRef
  10. Hiromatsu, Y, Tanaka, K, Sato, M, Kuroki, T, Nonaka, K, Kojima, K (1993) Intravenous methylprednisolone pulse therapy for Graves-ophthalmopathy. Endocr J 40: pp. 63-72 63" target="_blank" title="It opens in new window">CrossRef
  11. Tagami, T, Tanaka, K, Sugawa, H, Nakamura, H, Miyoshi, Y, Mori, T (1996) High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy. Endocr J 43: pp. 689-699 689" target="_blank" title="It opens in new window">CrossRef
  12. Kauppinen-M?kelin, R, Karma, A, Leinonen, E, L?yttyniemi, E, Salonen, O, Sane, T (2002) High dose intravenous methylprednisolone pulse therapy versus oral prednisone for thyroid-associated ophthalmopathy. Acta Ophthalmol Scand 80: pp. 316-321 600-0420.2002.800316.x" target="_blank" title="It opens in new window">CrossRef
  13. Ohtsuka, K, Sato, A, Kawaguchi, S, Hashimoto, M, Suzuki, Y (2002) Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves-ophthalmopathy. Jpn J Ophthalmol 46: pp. 563-567 6/S0021-5155(02)00544-0" target="_blank" title="It opens in new window">CrossRef
  14. Aktaran, S, Akarsu, E, Erba?ci, I, Araz, M, Okumu?, S, Kartal, M (2007) Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves-ophthalmopathy. Int J Clin Pract 61: pp. 45-51 6.01004.x" target="_blank" title="It opens in new window">CrossRef
  15. Geest, RJ, Sasim, IV, Koppeschaar, HP, Kalmann, R, Stravers, SN, Bijlsma, WR (2008) Methylprednisolone pulse therapy for patients with moderately severe Graves-orbitopathy: a prospective, randomized, placebo-controlled study. Eur J Endocrinol 158: pp. 229-237 CrossRef
  16. Mourits, MP, Koornneef, L, Wiersinga, WM, Prummel, MF, Berghout, A, Gaag, R (1989) Clinical criteria for the assessment of disease activity in Graves-ophthalmopathy: a novel approach. Br J Ophthalmol 73: pp. 639-644 6/bjo.73.8.639" target="_blank" title="It opens in new window">CrossRef
  17. Bartalena, L, Baldeschi, L, Dickinson, A, Eckstein, A, Kendall-Taylor, P, Marcocci, C (2008) Consensus statemen
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Ophthalmology
  
• 出版者：Springer Japan
• ISSN：1613-2246

文摘

Purpose To quantitatively evaluate the efficacy of methylprednisolone pulse therapy for extraocular muscle inflammation in thyroid-associated ophthalmopathy (TAO) using the short-tau inversion-recovery (STIR) technique of magnetic resonance imaging (MRI). Methods The signal intensities of the superior rectus (SR), inferior rectus (IR), lateral rectus (LR), medial rectus (MR), and superior oblique (SO) muscles were measured using the STIR images from 34 eyes of 17 patients with TAO before and after methylprednisolone pulse therapy and 19 eyes of 19 controls. The signal intensity ratio (SIR) of the signal intensity in muscles to that in brain white matter was calculated. Results The mean SIRs of the controls were 1.08?±?0.26 in the SR, 1.32?±?0.29 in the IR, 1.34?±?0.19 in the LR, 1.47?±?0.25 in the MR, and 1.28?±?0.22 in the SO muscles. SIRs exceeding 2.0 were out of the normal range. The SIRs of the patients with TAO before treatment were 2.19?±?0.64, 2.44?±?0.58, 1.96?±?0.43, 2.24?±?0.47, and 1.91?±?0.42, respectively, which was significantly (P?P? Conclusion Extraocular muscle inflammation in TAO improved with treatment. However, inflammation in some muscles persisted after treatment, and a high SIR in the muscle after treatment suggested the risk of deterioration of TAO.